MediMatch Group secures private equity investment from Queens Park Equity to fuel European expansion

MediMatch Group, a leading network of dental laboratories across the UK and Europe, has successfully secured a multi-million-pound private equity investment from Queens Park Equity (QPE) to accelerate its growth and expansion plans – with the help of Midlands law firm Shakespeare Martineau.

MediMatch Group provides dental lab products and services for both NHS and private practices. From acrylic dentures to intraoral scanners, the group utilises the latest in dental technology and training to help dental practices maximise business potential.

With the backing of QPE, the group is now positioned to accelerate its growth beyond organic expansion, with plans to enhance its operations, release equity and fund a robust expansion strategy, including a series of acquisitions in the UK and Europe.

Hugo van Loenen, CEO of MediMatch Group, said: “Securing private equity investment from Queens Park Equity is a pivotal moment for us. This funding provides us with the resources to expand rapidly and strategically, furthering our mission to provide innovative, top-tier dental laboratory services to our clients across the UK and Europe. We are excited about the future and the opportunities this investment will bring.”

The dental laboratory sector has seen an increasing interest from private equity investors, with QPE’s investment highlighting the sector’s growth potential. The deal also reflects a broader trend within the dental industry, where private equity is actively pursuing opportunities to scale and consolidate dental laboratory platforms, a space that is experiencing heightened demand.

Sami Igout, investor at Queens Park Equity, said: “MediMatch Group’s impressive track record and future growth potential made this investment an exciting opportunity for us. We are looking forward to supporting the group as they expand their footprint and continue to provide exceptional services to dental professionals across Europe.”

Jonathan Tyson, partner at Shakespeare Martineau, who led the deal, said: “Our team worked closely with Hugo and his team to ensure the terms of the transaction allowed for the future to be a healthy mix of entrepreneurial flair and accelerated but controlled growth.

“Our team worked tirelessly and diligently to ensure the transaction was completed within the required timescales and we are proud to have helped facilitate such a fantastic deal for both parties.

“With this investment, MediMatch Group is poised for rapid growth, with plans for significant expansion through acquisitions and further strengthening its position as a leading provider of dental laboratory services across Europe. We look forward to seeing and supporting the group’s continued success and growth in the coming years.”

Also supporting the deal were corporate specialists Jonathan Hill and Stena Rham, from Shakespeare Martineau, as well as tax expert Huw Witty, also at the firm. CMS acted as solicitors for Queens Park Equity, while KPMG and Cooper Parry provided financial and accounting input for QPE